Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y3M - Diabetes & Endocrinology > Non-insulin Treatments and Monitoring of Diabetes > Flashcards

Non-insulin Treatments and Monitoring of Diabetes Flashcards

1
Q

First line treatment of T2DM.

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Action of metformin.

A

Reduces rate of gluconeogenesis and hepatic glucose output

Increases insulin sensitivity

Suppress appetite

Stabilise weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metformin effects on plasma glucose levels.

A

Lowers fasting plasma glucose by 2-4 mmol/l

Fall of 11-22 mmol/mol of HbA1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adverse effects of metformin.

A

Anorexia

Nausea

Abdo discomfort

Diarrhoea

Lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When is metformin contraindicated?

A

Renal impairment

Cardiac failure

Hepatic failure

Intravascular administration of iodinated contrast agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the risk of giving metformin along with the contraindications?

A

Lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mode of action of sulphonylureas.

A

Act on beta-cells to induce insulin secretion.

Binds to receptor to close ATP-sensitive potassium channels and blocks the potassium efflux.

This leads to depolarisation and influx of calcium -> Insulin release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is sulphonylurea used?

A

Alternative first-line if metformin is contraindicated or not well tolerated.

Add-on.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sulphonylurea effects on plasma glucose and HbA1c.

A

Reduce fasting plasma glucose by 2-4 mmol/l

11-22 mmol/mol fall in HbA1c.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sulphonylureas effect long term.

A

Will reduce as B-cell mass declines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adverse effects of sulphonylureas.

A

Due to the increase in insulin there is typically weight gain of 1-4 kg.

Hypoglycaemia (increases in risk with alcohol intake, older age and intercurrent infection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are meglitinides?

A

Short-acting agents that promote insulin secretion in response to meals.

Act like sulphonylureas but designed to restore early-phase post-prandial insulin release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When are meglitinides used?

A

To treat people with post-prandial hyperglycaemia with normal fasting glucose levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADR of meglitinides.

A

Hypoglycaemia

Weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common (and in some countries the only available) Thiazolidinedione.

A

Pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mode of action of pioglitazone.

A

Reduce insulin resistance by interaction with PPAR-y.

Reduce hepatic glucose production.

Enhance peripheral glucose uptake

Potentiate the effect of endogenous or injected insulin.

Also promote TAG production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When is pioglitazone used?

A

Monotherapy

Add-on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Benefits of pioglitazone as monotherapy?

A

Do not cause hypoglycaemia on its own.

Specifically beneficial in people with non-alcoholic fatty liver diease.

(May take up to 3 months to reach its maximal effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ADRs of pioglitazone.

A

Weight gain of 5-6 kg

Can cause fluid retention leading to heart failure.

Mild anaemia

Osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Example of DPP-4 inhibitors.

A

Sitagliptin

Saxagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mode of action of DPP4i

A

Inhibit DPP4 leading to a prevention of rapid inactivation of GLP-1.

This leads to increased insulin secretion and reduces the glucagon secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When are DPP4i used?

A

Most effective in early stages of T2DM.

Currently second-line use in combination with metformin or sulphonylurea.

Usually well tolerated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benefits of DPP4i.

A

Do not promote weight gain

Low risk of hypoglycaemia

Safely used in renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ADRs of DPP4i.

A

Nausea

Acute pancreatitis

Saxagliptin might increase risk of heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

E.g. of SGLT2i.

A

Dapagliflozin

26
Q

Mode of action of SGLT2i.

A

Lowers the renal threshold for glucose.

Increasing urinary glucose excretion leading to removal of both glucose and calories from the body.

27
Q

SGLT2i effects on plasma glucose levels and weight.

A

Reduces blood glucose by 7-13 mmol/mol (???)

2-4 kg weight loss over 6-12 months

28
Q

When are SGLT2i used?

A

Monotherapy

Typically in combination

29
Q

Benefits of SGLT2i

A

Cardiovascular benefits

Low risk of hypo

Dependent on good renal function but is renoprotective.

Weight loss

30
Q

ADRs of SGLT2i

A

Genital candidiasis

Dehydration

Diabetic ketoacidosis

Fournier’s gangrene

Lower limb amputation

31
Q

Mode of action of alpha-glucosidase inhibitors.

A

Prevent alpha-glucosidase (last enzyme inolved in carb digestion) form breaking down disaccharides into monosaccharides.

Slows absorption of glucose after a meal.

32
Q

ADRs of alpha-glucosidase inhibitors.

A

Flatulence

Abdo distention

Diarrhoea

33
Q

E.g. of other rarely used oral therapies.

A

Quick release bromocriptine

Colesevelam

34
Q

Give an example of a non-insulin injectable therapy for T2DM.

A

GLP-1 receptor agonists.

35
Q

There are two types of GLP-1 receptors agonists.

Which?

A

Drugs derived from the protein exendin. This one is resistant to DPP-4 cleavage.

The second group are analogues of human GLP-1.

36
Q

How often are GLP-1 receptor agonists given?

A

Once-weekly.

37
Q

Mode of action of GLP-1 receptor agonists.

A

Enhance the incretin effect by activating GLP-1 recpetor.

They are more potent than DPP4is.

They act on pancreas to increase insulin secretion and decrease glucagon secretion.

They also act on the hypothalamus to reduce appetite and promote weight loss.

Short acting GLP-1s also slow gastric emptying.

38
Q

Benefits of GLP-1 receptor agonists.

A

Protect heart against ischaemic damage.

Lowers BP

Lowers free fatty acids.

39
Q

When are GLP-1 receptor agonists used?

A

Second or third-line therapy.

Should not be combined with DPP4i - no additional benefit.

40
Q

ADRs of GLP-1 receptor agonists.

A

Nausea

Vomiting

Bloating

Diarrhoea

Low risk of hypo.

Pancreatitis

41
Q

Individuals with established atherosclerotic cardiovascular disease.

What might you give?

A

GLP-1 receptor agonist

SGLT2i

42
Q

Diabetes with heart failure and chronic kidney disease.

A

SGLT2 inhibitor

43
Q

If there is a pressing need to minimise weight gain or pormote loss.

What should be given?

A

GLP-1 receptor agonists or SGLT2i

44
Q

What surgeries can be done in diabetes?

A

Islet transplantation (T1DM)

Whole pancrease transplantation (T1DM)

45
Q

Explain islet transplantation.

A

Harvesting pancreatic islets from cadavers (two or three needed)

Injected into the portal vein and seed themselves into the liver.

46
Q

When might islet transplanation be done?

A

In T1DM with hypoglycaemic unawareness, severe hypoglycaemic episodes and marked glucose variability.

47
Q

Treatment goal of islet transplantation.

A

Prevent severe hypoglycaemia.

50-70% of people receiving islet cell transplants also achieve insulin independence after 5 years.

48
Q

When might whole-pancrease transplantation be done?

A

T1DM in end-stage kidney disease.

This means that the pancreas transplantation is done when another transplant is done as well.

49
Q

Disadvantages of whole-pancrease transplantation.

A

Long-term immunosuppression.

50
Q

Ways of measuring the metabolic control of diabetes.

A

Short-term measures such as:

Self-monitoring of capillary blood glucose

Continuous glucose monitoring

Long-term measures such as:

Glycated haemoglobin HbA1c

Frucosamine

51
Q

When is self-monitoring of capillary blood glucose recommended?

A

For everyone treated with insulin.

Also some people with diet or tablet treated T2DM.

52
Q

Explain continuous glucose monitoring

A

Measures interstitial glucose every few minutes allowing the user to see trends in glucose throughout the day.

It is particularly good at night when testing is not usually done.

Freestyle Libre is a sort of continuous glucose monitoring.

53
Q

Two types of continuous glucose monitoring.

A

Real time

Retrospective

54
Q

Main disadvantage of CGM.

A

The lag of 15-20 minutes between changes in blood glucose and interstitial glucose.

This means that if there is an indication of hypoglycaemia the individual should test their capillary glucose as well.

55
Q

When is CGM recommended?

A

T1DM who have problematic hypoglycaemia.

Recurrent severe hyperglycaemia.

Impared awareness of hypoglycaemia

Extreme fear of hypoglycaemia.

56
Q

Explain glycated haemoglobin HbA1c.

A

Measure of an individual’s average blood glucose concentration over the previous 6-8 weeks.

This is because glucose will glycate the haemoglobin.

The rate at which it occurs is related to the glucose concentration in the blood.

57
Q

Limitations to HbA1c

A

Molecular variants of haemoglobin such as fetal Hb

Variation in red blood cell lifespan such as in haemolytic anemia, acute or chronic blood loss.

Pregnancy

Longer lifespan like in iron deficiency.

Renal failure

HIV infection.

58
Q

If there are known problems of anaemia or haemoglobinpathy, what can be used as a long-term measurement instead of HbA1c?

A

Glycation of albumin measured as fructosamine.

Only used rarely.

59
Q

T2DM diabetes treatment algorithm.

A
60
Q

Explain the diabetes health check.

A

Every 3-6 months you do an HbA1c (3monthly when newly diagnosed and then 6monthly when stable)

Annually

Feet

Eyes

BP, lipid profile, heart and kidney disease (Urine albumin:creatinine ratio + eGFR)

Weight check

Update on medication

Y3M - Diabetes & Endocrinology (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions